MRC Centre of Epidemiology for Child Health, UCL Institute of Child Health, London, UK.
J Viral Hepat. 2011 Aug;18(8):533-41. doi: 10.1111/j.1365-2893.2011.01128.x. Epub 2011 Jun 22.
Despite the introduction of blood donor screening, worldwide, children continue to become infected with hepatitis C virus (HCV) via un-sterile medical injections, receipt of unscreened blood and isolated hospital contamination outbreaks. It is plausible that the natural history and disease progression in these children might differ from that of their vertically infected counterparts. Vertically and parenterally HCV-infected children were prospectively followed within the European Paediatric HCV Network and the UK National HCV Register, respectively. Biological profiles were compared. Vertically and parenterally HCV-infected children differed in terms of some key characteristics including the male to female ratio and the proportion of children receiving therapy. Parenterally infected children were more likely to have at least one hepatomegaly event during follow-up, 20%vs 10%. Parenteral infection did not significantly affect the odds of being consistently viraemic (AOR 1.14, P = 0.703) and there was no significant difference in the odds of having consistently elevated ALT levels and mode of acquisition (AOR 0.83, P = 0.748). The proportion of children with 2 or more markers of HCV infection did not differ significantly by mode of acquisition (χ(2) 1.13, P = 0.288). This analysis does not support substantial differences between vertically and parenterally infected groups, but there are specific mechanisms identified requiring further investigation. Given the continued parenteral infection of children worldwide, it is vital that knowledge of disease progression in this group is accurate and that the differences in comparison with vertically infected children are clarified to inform more accurate and individualized clinical management.
尽管在全球范围内已经引入了献血者筛查措施,但儿童仍会通过非无菌医疗注射、接受未经筛查的血液以及孤立的医院污染爆发感染丙型肝炎病毒 (HCV)。这些儿童的自然史和疾病进展可能与垂直感染的儿童不同。在欧洲儿科 HCV 网络和英国国家 HCV 登记处,分别对垂直和经肠胃外 HCV 感染的儿童进行了前瞻性随访。比较了生物学特征。在一些关键特征方面,垂直和经肠胃外 HCV 感染的儿童存在差异,包括男女比例和接受治疗的儿童比例。经肠胃外感染的儿童在随访期间更有可能至少发生一次肝肿大事件,为 20%对 10%。经肠胃外感染并未显著影响持续病毒血症的几率(比值比 1.14,P = 0.703),持续 ALT 水平升高的几率和感染途径也无显著差异(比值比 0.83,P = 0.748)。感染途径不同,具有 2 个或更多 HCV 感染标志物的儿童比例无显著差异(χ(2) 1.13,P = 0.288)。这项分析不支持垂直和经肠胃外感染组之间存在实质性差异,但确定了需要进一步调查的特定机制。鉴于全世界仍在发生经肠胃外感染儿童,准确了解该组疾病进展情况并阐明与垂直感染儿童的差异以提供更准确和个体化的临床管理至关重要。